Zhang Junqi, Zhou Bin. Progresses of Companion Diagnostics Relatede Antitumor Drugs[J]. Chinese Journal of Modern Applied Pharmacy, 2018, 35(3): 454-459. DOI: 10.13748/j.cnki.issn1007-7693.2018.03.034
    Citation: Zhang Junqi, Zhou Bin. Progresses of Companion Diagnostics Relatede Antitumor Drugs[J]. Chinese Journal of Modern Applied Pharmacy, 2018, 35(3): 454-459. DOI: 10.13748/j.cnki.issn1007-7693.2018.03.034

    Progresses of Companion Diagnostics Relatede Antitumor Drugs

    • Companion diagnostics (CDx) and CDx related antitumor drugs develope very fast recently for the improvement of basic research of oncomolecular biology. Antitumor drugs is the largest branch of CDx nowadays. Doctors may prognosis drug effect by CDx, which is important in making treatment plan and individualized treatment. There are many differences between traditional chemotherapy drugs and CDx related drugs. Here is a review of companion diagnostics related antitumor drugs.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return